Safety The most frequently reported side effects of GLP-1RAs are of gastrointestinal (GI) origin, including nausea, vomiting, diarrhoea and obstipation and may be more common in patients with higher age, lower body weight, renal impairment, and if there is a history or currently smoking (75)
2021 : Wegovy, Novo Nordisks semaglutide injection for long-term weight management in adults, gets FDA approval
Additionally, any symptoms of severe gastroparesis or intestinal obstruction (severe abdominal pain, persistent vomiting, or inability to tolerate oral intake) warrant immediate medical evaluation
Archivado desde el original el 8 de mayo de 2007
Vitamin B-12 plays a crucial role in the production of red blood cells and the conversion of food into energy
Most providers require a minimum of 3 days between injections if you must adjust your schedule